Skip to main content
. Author manuscript; available in PMC: 2022 Sep 4.
Published in final edited form as: Eur J Epidemiol. 2021 Sep 4;36(9):965–974. doi: 10.1007/s10654-021-00800-1

Table 2.

Risk of glioma and glioblastoma in NHS, NHSII, and HPFS by categories of cumulative average total alcohol intake, and separately for alcohol intake from specific beverages.

All Glioma (n=554) Glioblastoma (n=362)
Grams Alcohol/Day Approximate Servings/Week Cases MV HRab 95%CI Cases MV HRab 95%CI
Total Alcohol 0–0.5 0–0.25 179 Ref. 115 Ref.
>0.5–2 >0.25–1 89 0.83 0.64–1.07 58 0.87 0.63–1.20
>2–8 >1–4 137 0.85 0.68–1.07 90 0.87 0.66–1.16
>8–15 >4–7.5 69 0.75 0.56–0.99 44 0.73 0.51–1.05
>15 >7.5 80 0.71 0.53–0.96 55 0.77 0.54–1.10
Beer 0–0.5 0–0.25 385 Ref. 241 Ref.
>0.5–2 >0.25–1 77 0.98 0.77–1.25 58 1.00 0.75–1.35
>2–8 >1–4 66 1.14 0.87–1.51 45 1.20 0.85–1.67
>8 >4 26 1.00 0.66–1.52 18 1.22 0.74–2.01
Red Wine 0–0.5 0–0.25 357 Ref. 226 Ref.
>0.5–2 >0.25–1 117 0.96 0.77–1.18 86 1.12 0.87–1.44
>2–8 >1–4 68 0.89 0.68–1.16 38 0.77 0.54–1.10
>8 >4 12 0.98 0.54–1.76 12 1.46 0.80–2.66
White Wine 0–0.5 0–0.25 310 Ref. 198 Ref.
>0.5–2 >0.25–1 148 0.95 0.78–1.16 103 1.05 0.82–1.34
>2–8 >1–4 76 0.76 0.59–0.98 46 0.74 0.53–1.03
>8 >4 20 0.92 0.58–1.45 15 1.16 0.67–1.99
Total Wine 0–0.5 0–0.25 247 Ref. 155 Ref.
>0.5–2 >0.25–1 154 0.99 0.80–1.21 103 1.07 0.83–1.38
>2–8 >1–4 103 0.79 0.62–1.00 67 0.82 0.61–1.10
>8 >4 50 0.90 0.65–1.24 37 1.04 0.71–1.52
Liquor 0–0.5 0–0.25 337 Ref. 218 Ref.
>0.5–2 >0.25–1 96 0.98 0.78–1.23 59 0.94 0.70–1.25
>2–8 >1–4 62 0.81 0.62–1.08 49 1.04 0.75–1.44
>8 >4 59 0.92 0.68–1.24 36 0.85 0.59–1.24
a

Adjusted for age (months), calendar year, smoking status (never vs. past vs. current), BMI (<25 kg/m2 vs. ≥25–<30 kg/m2 vs. ≥30 kg/m2), and total caloric intake (quintiles).

b

Calculated by fixed effect meta-analysis of all three cohorts. Abbreviations: BMI, body mass index; CI, confidence interval; HPFS, Health Professionals Follow-Up Study; HR, hazard ratio; MV, multivariable; NHS, Nurses’ Health Study; NHSII, Nurses’ Health Study II;